Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy CorMedix stock

Own CorMedix stock in just a few minutes.

CorMedix Inc is a biotechnology business based in the US. CorMedix shares (CRMD) are listed on the NASDAQ and all prices are listed in US Dollars. CorMedix employs 35 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in CorMedix

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CRMD – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

CorMedix share price

Use our graph to track the performance of CRMD stocks over time.

CorMedix shares at a glance

Information last updated 2021-04-28.
52-week range$3.47 - $17.93
50-day moving average $8.92
200-day moving average $8.77
Wall St. target price$20.90
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.64

Buy CorMedix shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy CorMedix stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

CorMedix financials

Revenue TTM $239,231
Gross profit TTM $34,385
Return on assets TTM -43.19%
Return on equity TTM -64.91%
Profit margin 0%
Book value $1.32
Market capitalisation $333.1 million

TTM: trailing 12 months

Shorting CorMedix shares

There are currently 2.5 million CorMedix shares held short by investors – that's known as CorMedix's "short interest". This figure is 3.9% down from 2.6 million last month.

There are a few different ways that this level of interest in shorting CorMedix shares can be evaluated.

CorMedix's "short interest ratio" (SIR)

CorMedix's "short interest ratio" (SIR) is the quantity of CorMedix shares currently shorted divided by the average quantity of CorMedix shares traded daily (recently around 612671.3592233). CorMedix's SIR currently stands at 4.12. In other words for every 100,000 CorMedix shares traded daily on the market, roughly 4120 shares are currently held short.

However CorMedix's short interest can also be evaluated against the total number of CorMedix shares, or, against the total number of tradable CorMedix shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CorMedix's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 CorMedix shares in existence, roughly 70 shares are currently held short) or 0.0672% of the tradable shares (for every 100,000 tradable CorMedix shares, roughly 67 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CorMedix.

Find out more about how you can short CorMedix stock.

CorMedix share dividends

We're not expecting CorMedix to pay a dividend over the next 12 months.

Have CorMedix's shares ever split?

CorMedix's shares were split on a 1:5 basis on 25 March 2019. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your CorMedix shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for CorMedix shares which in turn could have impacted CorMedix's share price.

CorMedix share price volatility

Over the last 12 months, CorMedix's shares have ranged in value from as little as $3.47 up to $17.93. A popular way to gauge a stock's volatility is its "beta".

CRMD.US volatility(beta: 2.38)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CorMedix's is 2.3751. This would suggest that CorMedix's shares are significantly more volatile than the average for this exchange and represent a higher risk.

CorMedix overview

CorMedix Inc. , a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. It primarily focuses on the development of its lead product candidate DefenCath/Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site